Back
Dyne Therapeutics Stock Price Chart

From 50,000 investors to Nasdaq? Mode's next move...
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Buy
56
DYN
Dyne Therapeutics
Last Price:
$14.39
Seasonality Move:
41.99%
7 Day Trial
ALL ACCESS PASS
$
7

Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing slight selling pressure.
Dyne Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.33 | Buy |
20-day SMA: | 12.47 | Buy |
50-day SMA: | 10.8 | Buy |
200-day SMA: | 21.96 | Sell |
8-day EMA: | 13.54 | Buy |
20-day EMA: | 12.56 | Buy |
50-day EMA: | 10.45 | Buy |
200-day EMA: | 4.76 | Buy |
Dyne Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.99 | Buy |
Relative Strength Index (14 RSI): | 68.64 | Buy |
Chaikin Money Flow: | -1308844 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.98 - 13.28) | Buy |
Bollinger Bands (100): | (10.01 - 14.27) | Buy |
Dyne Therapeutics Technical Analysis
May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Dyne Therapeutics Stock
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 14.40 while DYN 8-day simple moving average is 13.33, which is a Buy signal.
-
The stock price of DYN is 14.40 while Dyne Therapeutics 20-day SMA is 12.47, which makes it a Buy.
-
Dyne Therapeutics 50-day simple moving average is 10.80 while DYN share price is 14.40, making it a Buy technically.
-
DYN stock price is 14.40 and Dyne Therapeutics 200-day simple moving average is 21.96, creating a Sell signal.
DYN Technical Analysis vs Fundamental Analysis
Buy
56
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy or a Sell?
-
Dyne Therapeutics stock is rated a BuyThe current Dyne Therapeutics [DYN] share price is $14.40. The Score for DYN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Dyne Therapeutics Stock Info
Market Cap:
1.6B
Price in USD:
14.40
Share Volume:
3.6M
Dyne Therapeutics 52-Week Range
52-Week High:
47.45
52-Week Low:
6.36
Buy
56
Dyne Therapeutics (DYN)
is a Buy
Dyne Therapeutics Share Price Forecast
-
What is the Dyne Therapeutics stock price today?The Dyne Therapeutics stock price is 14.40 USD today.
-
Will DYN stock go up or go down?Dyne Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Dyne Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dyne Therapeutics is not overvalued.
Is Dyne Therapeutics Stock a Buy?
-
Dyne Therapeutics share price is 14.40 while DYN 8-day exponential moving average is 13.54, which is a Buy signal.
-
The stock price of DYN is 14.40 while Dyne Therapeutics 20-day EMA is 12.56, which makes it a Buy.
-
Dyne Therapeutics 50-day exponential moving average is 10.45 while DYN share price is 14.40, making it a Buy technically.
-
DYN stock price is 14.40 and Dyne Therapeutics 200-day simple moving average is 4.76, creating a Buy signal.
Fundamental Analysis of Dyne Therapeutics
Is Dyne Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.43 per share, and an increase next year of $0.12 per share.
Technical Analysis of Dyne Therapeutics
Should I short Dyne Therapeutics stock?
-
DYN Moving Average Covergence Divergence (MACD) indicator is 0.99, suggesting Dyne Therapeutics is a Buy
-
Dyne Therapeutics Relative Strength Index (RSI) is 68.64, which suggest Dyne Therapeutics is overbought
-
The Bollinger Bands (25) for Dyne Therapeutics is (10.98 - 13.28), which suggest Dyne Therapeutics is a Buy
-
The Bollinger Bands (100) for Dyne Therapeutics is (10.01 - 14.27), which suggest Dyne Therapeutics is a Buy
* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.